Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06806930

Recruiting

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Carcinoma, Breast
NCT06606730

Recruiting

Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer (OPT-PEMBRO)

Triple Negative Breast Cancer (TNBC) | Breast Cancers
NCT05786664

Recruiting

Breast Cancer Survivorship Biorepository

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma
NCT04305834

Recruiting

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Hormone Receptor Positive Breast Carcinoma | Metastatic Breast Carcinoma
NCT03737695

Active, not recruiting

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Metastatic Breast Carcinoma | Peritoneal Effusion
NCT05101096

Active, not recruiting

Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)

Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast Cancer
NCT02624700

Terminated

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Breast Cancer | Metastatic Breast Cancer | Recurrent Breast Cancer
NCT07005583

Not yet recruiting

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Triple-Negative Breast Cancer (TNBC)
NCT06217874

Recruiting

Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer

Breast Carcinoma | Recurrent Breast Carcinoma | Metastatic Breast Carcinoma
NCT04906369

Suspended

Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma
NCT04256941

Terminated

Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma
NCT03854903

Completed

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast Cancer
NCT03786354

Active, not recruiting

Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC v8 | Prognostic Stage IIB Breast Cancer AJCC v8
NCT07499089

Not yet recruiting

Together-Breast Cancer Support Platform (Together)

Breast Cancer | Breast Cancer Survivors
NCT07487844

Not yet recruiting

Pulsed Electric Field Ablation for Metastatic Breast Cancer

Breast Cancer | Metastatic Breast Cancer
NCT07185568

Not yet recruiting

IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving Surgery for Non-palpable Tumors (MANOLA)

Breast Cancer | Breast-Conserving Surgery
NCT07404462

Completed

Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer

Breast Cancer | Early Breast Cancer
NCT00842465

Completed

Prolactin Receptor and Breast Diseases (Prolacsein)

Breast Cancer | Benign Breast Disease
NCT01463072

Active, not recruiting

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

Recurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma
NCT05568472

Active, not recruiting

Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma
NCT05415215

Completed

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer (ProHer)

Inflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast Cancer
NCT06900023

Enrolling by invitation

The BEACON Trial: Diagnostic Tools for Breast Lymphedema After Treatment for Breast Cancer (BEACON)

Lymphedema | Lymphedema, Breast Cancer | Breast Lymphedema | Breast Edema
NCT06253195

Active, not recruiting

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast Cancer
NCT02037529

Suspended

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

Invasive Breast Carcinoma | HER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIC Breast Cancer AJCC v7 | Breast Adenocarcinoma
NCT03012230

Completed

Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer

Metastatic Malignant Neoplasm in the Bone | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7
NCT02219789

Completed

Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive
NCT07218432

Recruiting

A Study of the TheraBionic P1 Device in Breast Cancer

Breast Cancer Stage I | Breast Cancer Stage II | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Breast Cancer Stage IIIA
NCT05573126

Recruiting

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

Metastatic Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer
NCT04755868

Not yet recruiting

Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

TNBC - Triple-Negative Breast Cancer
NCT03932526

Not yet recruiting

Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer

Triple-negative Breast Cancer
NCT04085276

Completed

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment (TORCHLIGHT)

Triple-Negative Breast Cancer
NCT05173103

Completed

Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast Cancer (HERMIONE-13)

Advanced Breast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer
NCT07046195

Active, not recruiting

Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer

Immunotherapy | Triple Negative Breast Cancer (TNBC) | Hypofractionated Radiotherapy
NCT05169853

Active, not recruiting

Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer

Triple Negative Breast Cancer | HER2-positive Breast Cancer
NCT01339442

Completed

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer
NCT07600164

Not yet recruiting

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

Advanced Breast Cancer | HER2 + Breast Cancer
NCT07546695

Recruiting

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study (MACRONAC)

Breast Cancer
NCT07277738

Not yet recruiting

Precision Supplemental Imaging in Women With Dense Breasts (PSID)

Breast Cancer | Cancer of the Breast
NCT07242352

Recruiting

Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC (ADAPTela)

Breast Cancer | HR+/HER2- Breast Cancer
NCT07233928

Recruiting

Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers (ESPRESSOBREAST)

Metastatic Breast Cancer | Early Breast Cancer
NCT07083310

Not yet recruiting

The Effect of Health Education Conducted Using Two Different Methods on Women's Knowledge of Breast Cancer, Health Beliefs, Mammography Self-Efficacy, and Participation in Screening Programs

Breast Cancer | Breast - Female
NCT06039956

Not yet recruiting

De-escalating Axillary Surgery in Breast Cancer Patients in Nigeria

Breast Cancer | Axilla; Breast
NCT05505643

Recruiting

Cryoablation vs Lumpectomy in T1 Breast Cancers (COOL-IT)

Breast Cancer | Breast Neoplasm
NCT04888351

Recruiting

Immediate Breast Reconstruction's Increasing (IBRI)

Breast Cancer | Breast Reconstruction
NCT04769960

Active, not recruiting

Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy

Breast Cancer | Breast Neoplasms | Breast Adenocarcinoma
NCT05309265

Active, not recruiting

Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study (VocRehab)

Breast Cancer | Breast Neoplasm
NCT02759133

Completed

Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire (IodineBreast)

Breast Cancer
NCT02284919

Active, not recruiting

[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer (ISO-1Primary)

Breast Cancer | Breast Neoplasm
NCT03911453

Completed

Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors

Breast Cancer
NCT06049446

Completed

Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors (CEMMAG)

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations